https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431605/
COVID-19 vaccination and leprosy-A UK hospital-based retrospective cohort study
PLOS Neglected Tropical Diseases PLoS Negl Trop Dis. 2023 Aug; 17(8): e0011493.
Published online 2023 Aug 4. doi: 10.1371/journal.pntd.0011493
Whatever. RTFP and quit pissing on the people who flagged it.
Because ABCNNBCBS isn't going to tell you it exists.
If that is a response to my post above, I did
Read The F___ing (Original) Post and like
@Kamaji, pointed out the gaping hole in its claim, with a bit more detail. I did not link or allude to material from "ABCNNBCBS".
Anyway, looking at the study you linked:
* It was in the UK;
* It was a study of 52 people;
* These people all had had leprosy well (sometimes years) before being vaccinated for Covid;
* The study looked at whether Covid vaccination might cause complications for persons who both have leprosy
and are taking a "systemic immunosuppressant drug";
* The study was done because in the past complications had been observed in recipients of the BCG tuberculosis vaccine, because that vaccine activated the immune systems of leprosy patients receiving the immunosuppressant drug; the study's purpose was to see if Covid vaccines might also cause similar complications for immuno-suppressed leprosy patients;
* Among those 52 leprosy patients studied, 2 had not been vaccinated against Covid, and 2 had a leprosy reaction that might have been due to the Covid vaccine stimulating their suppressed immune system.
The Conclusion from the Abstract:
The development of BT leprosy and a Type 1 reaction in another individual shortly after a dose of BNT162b2 vaccine may be associated with vaccine mediated T cell responses. The benefits of vaccination to reduce the risk of severe COVID-19 outweigh these unwanted events but data from leprosy endemic countries may provide further information about potential adverse effects of augmented T cell responses in individuals with leprosy or latent M. leprae infection.
In plainer English, while stating that further study is warranted and could alter the conclusion, based on the study the risk of Covid to immuno-suppressed leprosy patients is greater than the risk of a leprosy reaction.
&&&&&&&&&&&&&&&&&&
Reading between the lines of the study Abstract, the leprosy patients studied may either be from outside of the UK or at least some were. Two clues suggest this. M. leprae infection is described as a tropical disease, not endemic in the UK. One of the patients who had had a leprosy reaction had received CoronaVac about a month before receiving one dose of the BNT162b2 vaccine (Pfizer, in the US). CoronaVac is a Chinese vaccine that uses inactivated virus technology. Coronavac is not used in the UK (or the US), hence the leprosy patient had received CoronaVac outside of the UK.
In sum, this UK study addressed a
hypothetical concern for persons who already have leprosy
and are taking immuno-suppressant drug(s). If the
Natural News 
article in the OP references this study, the headline, at least, misrepresents the study really badly (or is simply lying about it). Whether in ignorance or lying,
Natural News 
is crying wolf.